1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 02 MARCH 2015

Cancer Drug News 02 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Targeted Medicine Increasing Orphan Diseases
Industry Brief - Halaven Approved In Saudi Arabia
Industry Brief - FDA Approves Novartis' Farydak For MM
Industry Trend Analysis - Alvocidib ODD Highlights Increasing Interest In AML
Industry Brief - EMA Accepts Kyprolis MAA For Relapsed MM
Industry Brief - Kyprolis Shows Superiority Over Velcade In Relapsed MM
Industry Brief - Eisai's Lenvatinib Extends OS In Phase II NSCLC Trial
Industry Trend Analysis - Opdivo Set To Become First PD-1 Inhibitor On NSCLC Market Ahead Of Keytruda
Industry Brief - Zykadia Gains CHMP Positive Opinion For ALK+ NSCLC Previously Treated With Crizotinib
Industry Brief - Abraxane Gains EU Approval For First-Line NSCLC
Industry Brief - Gradalis Initiates Vigil Phase III Registration Trial In OC
Industry Brief - Abraxane Reimbursed In Italy For First-Line MPC
Industry Brief - GVAX Pancreas/CRS-207/Opdivo Combination Phase II Trial Initiated
Industry Brief - CHMP Recommends Expanded Vectibix Use
Industry Brief - Taiho Submits TAS-102 MAA To EMA For Refractory MCRC
Industry Brief - Zelboraf Launched In Japan
Industry Brief - FDA Accepts Yervoy sBLA As Adjunctive Treatment For Stage III Melanoma
Industry Brief - Lenvima Available In US Through Accredo And Biologics Pharmacies
Industry Brief - Halaven Phase III Trial Meets Primary Endpoint Of OS In STS
Industry Trend Analysis - Array To Benefit From Novartis' GSK Oncology Acquisition
Industry Brief - GSK Set To Complete Acquisition Of Novartis' Vaccines Business
Industry Trend Analysis - Pharmacyclics Seeking Potential Suitors
Industry Brief - Cancer Conferences - June 2015

Table Of Contents

Cancer Drug News 02 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.